1. Sadeghi, B., E. Roshandel, A. Pirsalehi, S. Kazemi and G. Sankanian et al., 2021. Conquering the cytokine storm in COVID-19-induced ARDS using placenta-derived decidua stromal cells. J. Cell Mol. Med., 25: 10554-10564.
   CrossRef  |  Direct Link  |  
2. Ringden, O., M. Remberger, J. Tárlen, S. Finnbogadottir, B.M. Svahn and B. Sadeghi, 2021. Cytokine levels following allogeneic hematopoietic cell transplantation: A match-pair analysis of home care versus hospital care. Int. J. Hematol., 113: 712-722.
   CrossRef  |  Direct Link  |  
3. Sadeghi, B., B. Ersmark, G. Moretti, J. Mattsson and O. Ringden, 2020. Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells. Int. J. Hematol., 111: 591-594.
   CrossRef  |  Direct Link  |  
4. Ringden, O., B. Gustafsson and B. Sadeghi, 2020. Mesenchymal stromal cells in pediatric hematopoietic cell transplantation a review and a pilot study in children treated with decidua stromal cells for acute graft-versus-host disease. Front. Immunol., Vol. 11. 10.3389/fimmu.2020.567210.
   CrossRef  |  Direct Link  |  
5. Kazemi, S., K. Parivar, N.H. Roudbari, P. Yaghmaei and B. Sadeghi, 2020. Growth kinetic comparison of human mesenchymal stem cells from bone marrow, adipose tissue and decidua. Med. Sci., 24: 223-234.
   Direct Link  |  
6. Amin, R., R. He, D. Gupta, W. Zheng and M. Burmakin et al., 2020. The kidney injury caused by the onset of acute graft-versus-host disease is associated with down-regulation of αKlotho. Int. Immunopharmacol., Vol. 78. 10.1016/j.intimp.2019.106042.
   CrossRef  |  Direct Link  |  
7. Ringden, O., M. Remberger, B. Gustafsson, G. Moretti, J. Mattsson, J. Winiarski and B. Sadeghi, 2019. The outcome of allogeneic hematopoietic stem cell transplantation for inherited diseases is influenced by HLA match, year of transplantation, and immunized female donor. Transplantation, 103: 1247-1252.
   CrossRef  |  Direct Link  |  
8. Imani, M., S. Kazemi, M. Saviz, L. Farahmand, B. Sadeghi and R. Faraji-Dana, 2019. Morphological changes induced by extremely low-frequency electric fields. Bioelectromagnetics, 40: 375-390.
   CrossRef  |  Direct Link  |  
9. Ringden, O., M. Labopin, B. Sadeghi, A. Mailhol and D. Beelen et al., 2018. What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease? J. Intern. Med., 283: 166-177.
   CrossRef  |  Direct Link  |  
10. Ringden, O., B. Sadeghi, G. Moretti, S. Finnbogadottir and B. Eriksson et al., 2018. Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. Int. J. Hematol., 107: 478-485.
    CrossRef  |  Direct Link  |  
11. Ringden, O., A. Baygan, M. Remberger, B. Gustafsson and J. Winiarski et al., 2018. Placenta-derived decidua stromal cells for treatment of severe acute graft-versus-host disease. Stem Cells Transl. Med., 7: 325-331.
    CrossRef  |  Direct Link  |  
12. Ringden, O., M. Labopin, C. Schmid, B. Sadeghi and E. Polge et al., 2017. Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: A survey from the acute leukaemia working party of EBMT. Br. J. Haematol., 176: 431-439.
    CrossRef  |  Direct Link  |  
13. Gustafsson, B., P. Frisk, A. Szakos, B. Sadeghi, O. Ringden and B.M. Frost, 2017. Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease. Pediatr. Transplant., Vol. 21. 10.1111/petr.12990.
    CrossRef  |  Direct Link  |  
14. Baygan, A., W. Aronsson-Kurttila, G. Moretti, B. Tibert and G. Dahlláf et al., 2017. Safety and side effects of using placenta-derived decidual stromal cells for graft-versus-host disease and hemorrhagic cystitis. Front. Immunol., Vol. 8. 10.3389/fimmu.2017.00795.
    CrossRef  |  Direct Link  |  
15. Abedi-Valugerdi, M., J. Wolfsberger, P.R. Pillai, W. Zheng, B. Sadeghi, Y. Zhao and M. Hassan, 2016. Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice. Int. Immunopharmacol., 40: 41-49.
    CrossRef  |  Direct Link  |  
16. Sadeghi, B., Y. Heshmati, B. Khoein, H. Kaipe, M. Uzunel, J. Walfridsson and O. Ringden, 2015. Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo. Cytotherapy, 17: 1732-1745.
    CrossRef  |  Direct Link  |  
17. Ringden, O., M. Solders, T. Erkers, S. Nava and P. Mollden et al., 2015. Placenta-derived decidual stromal cells for graft-versus-host disease, hemorrhaging, and toxicity after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant., Vol. 21. 10.1016/j.bbmt.2014.11.209.
    CrossRef  |  Direct Link  |  
18. Moll, G., L. Ignatowicz, R. Catar, C. Luecht and B. Sadeghi et al., 2015. Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua. Stem Cells Dev., 24: 2269-2279.
    CrossRef  |  Direct Link  |  
19. Kaipe, H., L.M. Carlson, T. Erkers, S. Nava and P. Mollden et al., 2015. Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients. Stem Cells Dev., 24: 1471-1482.
    CrossRef  |  Direct Link  |  
20. Ringden, O., M. Uzunel, B. Sadeghi, M. Solders, M. Uhlin, J. Mattsson and M. Remberger, 2014. decreased risk of acute graft-versus-host disease using reduced intensity conditioning compared to myeloablative conditioning is independent of donor-recipient t-cell chimerism. J. Transplant Technol. Res., Vol. 4. 10.4172/2161-0991.1000142.
    CrossRef  |  Direct Link  |  
21. Kaipe, H., T. Erkers, B. Sadeghi and O. Ringden, 2014. Stromal cells-are they really useful for GVHD? Bone Marrow Transplant., 49: 737-743.
    CrossRef  |  Direct Link  |  
22. Sadeghi, B., H. Al-Chaqmaqchi, S. Al-Hashmi, D. Brodin and Z. Hassan et al., 2013. Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target? Bone Marrow Transplantation, 48: 284-293.
    CrossRef  |  PubMed  |  Direct Link  |  
23. Sadeghi, B. and O. Ringden, 2013. Mesenchymal Stem Cells for Graft Versus Host Disease in Experimental Animal Models. In: Stem Cell Dependent Therapies, Gross, G. and T. Haupl (Eds.). De Gruyter, Berlin.
24. Ringden, O., B. Sadeghi, 2013. Mesenchymal Stem Cells for Clinical/Therapeutic Interventions of Graft Versus Host Disease. In: Stem Cell Dependent Therapies Gross, G. and T. Haupl (Eds.). De Gruyter, Berlin.
25. Hashmi, S.A., B. Sadeghi, Z. Hassan, M. Abedi-Valugerdi and M. Lindskog et al., 2013. Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion. Bone Marrow Transplantation, 48: 843-848.
    CrossRef  |  PubMed  |  Direct Link  |  
26. Al-Chaqmaqchi, H., B. Sadeghi, M. Abedi-Valugerdi, S. Al- Hashmi, M. Fares and R. Kuiper, et al., 2013. The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host disease. PLOS ONE, 10.1371/journal.pone.0060367.
    CrossRef  |  PubMed  |  Direct Link  |  
27. Ringden, O. and B. Sadeghi, 2012. Is graft-versus-leukemia more effective using reduced-intensity conditioning compared with myeloablative conditioning? Biol. Blood Marrow Transplant, 18: 1615-1617.
    CrossRef  |  PubMed  |  Direct Link  |  
28. Al-Hashmi, S., P.J.M. Boels, F. Zadjali, B. Sadeghi and J. Sallstrom et al., 2012. Busulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthase. PLoS ONE, 10.1371/journal.pone.0030897.
    CrossRef  |  PubMed  |  Direct Link  |  
29. Sadeghi, B., H. Hagglund, M. Remberger, S. Al-hashmi, Z. Hassan, M. Abedi-Valugerdi and M. Hassan, 2011. Glucosamine activates T lymphocytes in healthy individuals and may induce GVHD/GVL in stem cell transplanted recipients. Open Transplant. J., 5: 1-7.
    Direct Link  |  
30. D'Arcy, P., S. Brnjic, M.H. Olofsson, M. Fryknas and K. Lindsten et al., 2011. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat. Med., 17: 1636-1640.
    CrossRef  |  PubMed  |  Direct Link  |  
31. Al-Hashmi, S., Z. Hassan, B. Sadeghi, B. Rozell and M. Hassan, 2011. Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen. Int. J. Clin. Exp. Pathol., 4: 596-605.
    PubMed  |  Direct Link  |  
32. Sadeghi, B., S. Al-Hashmi, Z. Hassan, B. Rozell and H. Concha et al., 2010. Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning. Clin. Dev. Immunol., 10.1155/2010/142943.
    CrossRef  |  PubMed  |  Direct Link  |  
33. Sadeghi, B., N. Aghdami, Z. Hassan, M. Forouzanfar, B. Rozell, M. Abedi-Valugerdi and M. Hassan, 2008. GVHD after chemotherapy conditioning in allogeneic transplanted mice. Bone Marrow Transplant., 42: 807-818.
    CrossRef  |  PubMed  |  Direct Link  |  
34. Sadeghi, B., M. Jansson, M. Mints, Z. Hassan, M. Abedi-Valugerdi and M. Hassan, 2008. The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model. Bone Marrow Transplant., 41: 895-904.
    CrossRef  |  PubMed  |  Direct Link  |  
35. Mints, M., M. Jansson, B. Sadeghi, M Westgren, M. Uzunel, M. Hassan and J. Palmblad, 2008. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Human Reproduct., 23: 139-143.
    PubMed  |  
36. Masoompour, S.M., M.H. Bagheri, B.A. Haghighi, Y.A. Novitsky and B. Sadeghi et al., 2008. Effect of ANGIPARS^™, a new herbal drug on diabetic foot ulcer: A phase 2 clinical study. DARU, 16: 31-34.
    Direct Link  |  
37. Khorshid, H.R.K., B. Sadeghi, R. Heshmat, M. Abdollahi, P. Salari, B. Farzamfar and S.H. Madani, 2008. In vivo and in vitro genotoxicity studies of Semelil (ANGIPARSTM). DARU J. Pharm. Sci., 16: 20-24.
    Direct Link  |  
38. Said, R., M. Abdel-Rehim, B. Sadeghi, S. Al-Hashemi, Z. Hassan and M. Hassan, 2007. Cyclophosphamide Pharmacokinetics in Mice: A Comparison between retro orbital sampling versus serial tail vein bleeding. Open Pharmaco. J., 1: 30-35.
    Direct Link  |  
39. Shiva, F., M. Nasiri, B. Sadeghi and M. Padyab, 2003. Effects of passive smoking on common respiratory symptoms in young children. Acta Paediatr, 92: 1394-1397.
    CrossRef  |  PubMed  |  Direct Link  |  
40. Haidari, M., E. Javadi, B. Sadeghi, M. Hajilooi and J. Ghanbili, 2001. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin. Biochem., 33: 309-315.
    CrossRef  |  PubMed  |  Direct Link  |